Gonadotrophin replacement for induction of fertility in hypogonadal men

被引：72
|
作者：
Dwyer, Andrew A. [1 ]
Raivio, Taneli [2 ,3 ]
Pitteloud, Nelly [1 ,4 ]
机构：
[1] CHU Vaudois, Endocrinol Diabet & Metab Serv, CH-1011 Lausanne, Switzerland
[2] Univ Helsinki, Inst Biomed Physiol, Helsinki, Finland
[3] Helsinki Univ Cent Hosp, Childrens Hosp, Helsinki, Finland
[4] Univ Lausanne, Fac Biol & Med, CHU Vaudois, Inst Physiol & Endocrinol,Diabet & Metab Serv, CH-1011 Lausanne, Switzerland
来源：
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM | 2015年 / 29卷 / 01期
关键词：
GnRH deficiency; Kallmann syndrome; hypogonadotrophic hypogonadism; male fertility; gonadotrophin therapy; fertility treatment; fertility outcomes; HUMAN CHORIONIC-GONADOTROPIN; FOLLICLE-STIMULATING-HORMONE; INTRACYTOPLASMIC SPERM INJECTION; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT HUMAN FSH; ANTIMULLERIAN HORMONE; LUTEINIZING-HORMONE; KALLMANN-SYNDROME; MALE-INFERTILITY; AZOOSPERMIC MEN;
D O I：
10.1016/j.beem.2014.10.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Congenital hypogonadotrophic hypogonadism (CHH) is a rare form of infertility caused by deficient secretion or action of gonadotrophin-releasing hormone. There is no consensus regarding the optimal approach to fertility treatment in CHH men. In most cases, appropriate hormonal treatment with human chorionic gonadotrophin with or without follicle stimulating hormone will induce testicular development, spermatogenesis and fertility. Recent studies have examined sequential treatment with FSH pretreatment to optimize fertility outcomes in severely affected CHH patients. This paper reviews historical and recent literature to summarize the current evidence on therapeutic approaches for CHH men seeking fertility. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码：91 / 103
页数：13
相关论文
共 50 条
  • [31] NON-PROPRIETARY SUBCUTANEOUS TESTOSTERONE REPLACEMENT THERAPY FOR HYPOGONADAL MEN
    Mossack, S.
    Spellman, A.
    Desouky, E.
    Nabulsi, O.
    Loos, D.
    Levine, L.
    JOURNAL OF SEXUAL MEDICINE, 2024, 21
  • [32] TESTOSTERONE REPLACEMENT THERAPY AND SLEEP-RELATED ERECTIONS IN HYPOGONADAL MEN
    CUNNINGHAM, GR
    HIRSHKOWITZ, M
    KORENMAN, SG
    KARACAN, I
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (03): : 792 - 797
  • [33] Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression
    Seidman, SN
    Rabkin, JG
    JOURNAL OF AFFECTIVE DISORDERS, 1998, 48 (2-3) : 157 - 161
  • [34] Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men
    Liu, PY
    Turner, L
    Rushford, D
    McDonald, J
    Baker, HWG
    Conway, AJ
    Handelsman, DJ
    HUMAN REPRODUCTION, 1999, 14 (06) : 1540 - 1545
  • [35] RACIAL DIFFERENCES IN HYPOGONADAL IMPROVEMENT AND PROSTATE-SPECIFIC ANTIGEN IN HYPOGONADAL MEN TREATED WITH TESTOSTERONE REPLACEMENT THERAPY
    Coward, Robert
    Simhan, Jay
    Pruthi, Raj
    Carson, Culley
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 41 - 41
  • [36] Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement
    Gerstenbluth, RE
    Maniam, PN
    Corty, EW
    Seftel, AD
    JOURNAL OF ANDROLOGY, 2002, 23 (06): : 922 - 926
  • [37] Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy
    Bernini, G
    Versari, D
    Moretti, A
    Cipriano, A
    Virdis, A
    Ghiadoni, L
    Bardini, M
    Taurino, C
    Taddei, S
    Salvetti, A
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 177A - 177A
  • [38] TESTOSTERONE REPLACEMENT THERAPY IN OPIOID-INDUCED HYPOGONADAL MEN: A PROSPECTIVE ANALYSIS
    Sisul, D.
    Acevedo, J.
    Raheem, O.
    Hsieh, T.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 119 - 120
  • [39] Testosterone Replacement Therapy Improves QTaVI in Hypogonadal Men with Spinal Cord Injury
    La Fountaine, Michael F.
    Wecht, Jill M.
    Cirnigliaro, Christopher M.
    Kirshblum, Steven C.
    Spungen, Ann M.
    Bauman, William A.
    NEUROENDOCRINOLOGY, 2013, 97 (04) : 341 - 346
  • [40] THE UTILITY OF ALKALINE PHOSPHATASE AS A MARKER FOR RESPONSE TO TESTOSTERONE REPLACEMENT THERAPY IN HYPOGONADAL MEN
    Sheng, John
    Sapin, Ari
    Benson, Michael
    Sadeghi-Nejad, Hossein
    JOURNAL OF UROLOGY, 2017, 197 (04): : E465 - E465
12345